MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2022 International Congress

    Temporal Dynamic Alterations of Regional Homogeneity in Parkinson’s disease: A Resting-State fMRI Study

    T. Yuan, L. Kai, S. Wen (Beijing, China)

    Objective: We aimed to test the differences of dynamic regional homogeneity (dReHo) between PD patients and healthy controls (HCs), and explore whether dReHo can be…
  • 2022 International Congress

    To Prescribe or Not to Prescribe: Assessing the impact of Parkinson’s nurse prescribers

    A. Hand, K. Mcewan, A. Clarke, A. Bate, S. Dalkin, R. Bradford, C. Allen, K. Mcdonald, S. Mccarthy, K. Brittain (Newcastle upon Tyne, United Kingdom)

    Objective: Within the UK, after successful completion of a formally recognised programme Parkinson’s Nurse Specialists (PNS) can act as independent prescribers, and as part of…
  • 2022 International Congress

    Dopamine-independent cortical disinhibition in Parkinson’s disease

    C. Ammann, M. Dileone, C. Pagge, D. Mata-Marín, M. Matarrazzo, M. Monje, A. Sánchez-Ferro, B. Fernández-Rodríguez, C. Gasca-Salas, J. Máñez-Miró, R. Martínez-Fernández, L. Vela, F. Alonso-Frech, A. Oliviero, JA. Obeso, G. Foffani (Móstoles, Spain)

    Objective: To test the hypothesis that cortical disinhibition in Parkinson's disease is a dopamine-independent process. Background: Motor cortex alterations in Parkinson's disease are classically considered…
  • 2022 International Congress

    Phantom boarder syndrome associated with experimentally-induced presence hallucinations in Parkinson’s disease

    J. Potheegadoo, F. Bernasconi, O. Blanke (Geneva, Switzerland)

    Objective: Measuring experimentally-induced presence hallucinations in patients with Parkinson’s disease phantom boarder phenomena. Background: Phantom boarder syndrome (PB) is described as the sensation that someone…
  • 2022 International Congress

    Designing a multi-arm multi-stage trial for Parkinson’s

    M-L. Zeissler, M. Burnell, T. Barber, Y. Ben-Shlomo, R. Chapman, C. Clarke, C. Counsell, M. Edwards, R. Ellis-Doyle, C. Gonzales-Robles, A. Jewell, G. Mills, J. Rudiger, D. Salathiel, S. Whipps, A. Whone, T. Foltynie, C. Carroll, R. Barker, J. Carpenter (Plymouth, United Kingdom)

    Objective: The Edmond J Safra ACT-PD initiative (EJS ACT-PD) is developing the first multi-arm multi-stage (MAMS) platform trial for potential disease modifying approaches for Parkinson’s…
  • 2022 International Congress

    Spectral somatotopy of the human subthalamic nucleus in Parkinson’s disease

    A. Averna, I. Debove, A. Nowacki, K. Peterman, E. Bernasconi, M. Sousa, L. Alva, L. Lachenmayer, M. Schuepbach, C. Pollo, P. Krack, K. Nguyen, G. Tinkhauser (Bern, Switzerland)

    Objective: This study aims to systematically investigate the spatial segregation of a wide range of spectral features of local field potentials (LFPs) within the STN…
  • 2022 International Congress

    Social cognition in Parkinson’s disease

    G. Siripurapu, R. Rajan, D. M R, E. A, A. Gupta, V. V Y, M. Singh, R. Bhatia, M. Tripathi, A. Srivastava, M. Srivastava, B. Verma, D. Biswas (NEW DELHI, India)

    Objective: Objective: To assess deficits in social cognition among patients with Parkinson’s Disease (PD) Background: Background: Social cognition is the study of how people make…
  • 2022 International Congress

    Utilisation of the Clinical Frailty Scale to prompt transfer of patients with Parkinson’s disease from Neurology to Geriatric Medicine services.

    A. Thomson, T. Jones, C. Chan, C. Miller (Salford, United Kingdom)

    Objective: The aim of this study was to determine the feasibility of the Clinical Frailty Scale (CFS) as a tool to trigger clinicians' transfer of…
  • 2022 International Congress

    MRI biomarkers of freezing of gait development in in Parkinson’s disease

    E. Sarasso, S. Basaia, C. Cividini, T. Stojkovic, I. Stankovic, N. Piramide, A. Tomic, V. Markovic, E. Stefanova, VS. Kostic, M. Filippi, F. Agosta (Milano, Italy)

    Objective: This study investigated longitudinal clinical, structural and functional brain alterations in Parkinson’s disease patients with freezing of gait (PD-FoG) and in those developing (PD-FoG-converters)…
  • 2022 International Congress

    Heterozygous mutations in the Parkin gene – two different presentations of Parkinson’s disease

    F. Barros, J. Alves, D. Reis-Carneiro, F. Moreira, A. Morgadinho (Coimbra, Portugal)

    Objective: The main objective of this work is to present two Parkinson's disease (PD) patients with heterozygous mutations in the Parkin gene (PARK – parkin)…
  • « Previous Page
  • 1
  • …
  • 482
  • 483
  • 484
  • 485
  • 486
  • …
  • 553
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley